(Q42447153)

31 October 2017

title

PON1 activities and oxidative markers of LDL in patients with angiographically proven coronary artery disease (English)

1 reference

31 October 2017

1 reference

Elif Azarsiz

1

1 reference

31 October 2017

Meral Kayikcioglu

series ordinal

2

1 reference

31 October 2017

Serdar Payzin

series ordinal

3

1 reference

31 October 2017

Eser Yildirim Sözmen

series ordinal

4

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

International Journal of Cardiology

31 October 2017

published in

1 reference

31 October 2017

volume

91

1 reference

31 October 2017

issue

1

1 reference

31 October 2017

page(s)

43-51

1 reference

Atherosclerosis — An Inflammatory Disease

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

The oxidative modification hypothesis of atherogenesis: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

Low density lipoprotein oxidation and its pathobiological significance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

Antioxidants, but not B-group vitamins increase the resistance of low-density lipoprotein to oxidation: a randomized, factorial design, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

Paraoxonase as a risk marker for cardiovascular disease: facts and hypotheses

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

Antioxidant enzymes and human diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratios may implicate poor glycemic control

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

Susceptibility to in vitro lipid peroxidation of low density lipoproteins and erythrocyte membranes from liver cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

Increased oxidation of LDL in patients with coronary artery disease is independent from dietary vitamins E and C

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

Cardiovascular syndromes X, endothelial dysfunction and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

Human serum paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

Antioxidant enzyme activities and total nitrite/nitrate levels in the collar model. Effect of nicardipine

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

Cardiac markers and risk stratification: an integrated approach

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2802%2900595-8

7 January 2021

10.1016/S0167-5273(02)00595-8

Identifiers

DOI

1 reference

31 October 2017

1 reference